SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES

Discover, develop & get to market by assessing the latest data and business strategies from global RNA experts across the entire RNA ecosystem - mRNA vaccines & therapeutics, short & non-coding RNAs, non-linear RNA, gene editing, delivery solutions & RNA as a target.

 

September 4-5, 2024
San Diego Convention Center, USA


PARTNERING LOGIN


Created by

LSX - The network for life science executive leaders

 

Discussions include: 

Antisense Technologies Circular RNA
CRISPR, RNA & Gene Editing Gene Therapy Approaches
lncRNA MicroRNA
mRNA Therapeutics mRNA Vaccines
Nucleic Acid Therapeutics RNA Activation
RNA Cell Therapy RNA Delivery
RNA Diagnostics RNA Epigenetics
RNA Interference Self-amplifying RNA
Small Molecules Targeting RNA tRNA
Discovery Pre-Clinical Clinical Manufacturing Commercialization

Why RNA Leaders?

RNA Leaders Venn

 

Join the leading RNA dedicated forum delivering access to business partnering opportunities with your C-level biotech, pharmaceutical heads and industry peers.

  • Discover the latest R&D advancements across multiple RNA modalities - mRNA vaccines & therapeutics, Oligo-based therapeutics, and Next-generation RNA (circRNA, saRNA, RNA & genome editing, small molecules and drug delivery)

  • Develop collaborations and solutions with RNA Biotechs (C-suite) and Large Pharma (VP and above) from leaders in field including Moderna, Alnylam, Eli Lilly, Ionis, Sanofi & BioNTech to tackle the number one challenge - delivery!

  • Get to market efficiently as RNA Leaders is not only purely scientific but also business-focused, giving you access to a highly sophisticated 1:1 partnering app, which facilitated over 450 partnering meetings at the 2023 Congress


And in the words of Moderna’s CSO, Melissa Moore, “when I saw some other speakers who had been invited, I felt this would be a really great place to connect with and network with my peers”.

Meet 2023 speakers - BioNTech, Ionis, J&J & more!

SEE ALL SPEAKERS

Key areas of focus

mRNA Vaccines & Therapeutics

Delve into process development mRNA therapeutics and saRNA approaches. Including:

  • Advancing mRNA Vaccine Technologies To Improve Stability, Efficacy & Delivery
  • Increasing RNA Based Medicine Safety Profiles via saRNA Preclinical Development
  • Moving mRNA From The Research Lab To Commercial Manufacturing
  • Innovating And Producing R&D And GMP mRNA
  • Route To Clinic – Critical Steps For mRNA Process Optimization

Oligo-based Therapeutics

Explore movement to clinic of ASOs, siRNA and short RNAs. Including:

  • RNAi Therapeutics Targeting Tumor Microenvironment 
  • Organophosphorus Process Strategies In Oligonucleotide Synthesis 
  • ASOs In The Neurodegenerative Disease Space
  • Empowering Enhanced Oligo Delivery To Improve RNA Modulating Therapies In Rare Muscle Diseases
  • Utilizing Endolysosomal Trafficking To Enhance Effective Oligo Delivery Safely

Next Generation RNA

Venture into emerging applications of RNA 2.0 such circRNA, lncRNAs, RNA editing, delivery tools and RNA as target. Including:

  • RNA to deliver RNA’ – Programmable Delivery Systems For Targeted Non-hepatic Delivery 
  • Next-Generation Lipid Nanoparticle Technology Enabling Extrahepatic Nucleic Acid Delivery
  • Utilizing Transcriptome-Wide Screening To Identify RNA Targets
  • Targeting Age-Related Diseases with Controllable Self-Replicating RNAs
  • Precision tRNA Reprogramming — New Approaches To Correcting Translational Dysfunction In Cancer

600+

Attendees

120+

Speakers

4

Tracks

2

Innovation Showcase Sessions

40hrs

networking

25+

Specialist Investors

50+

Partners

85+

Sessions

 

 

Meet our partners

LSX RNA Leaders USA Testimonial 01
quote mark

Great insights about technological innovations that pharma/investors would like to see in the coming years.

Aptadel Therapeutics

LSX RNA Leaders USA Testimonial 02
quote-gray

LSX are particularly good at bringing together a high quality network and facilitating new connections to allow best practice to be shared.

Vitality

LSX RNA Leaders USA Testimonial 03
quote-gray

RNA leaders congress brought startups and established pharmaceutical companies in a single platform. Helps to share the value and views of experts in the field and expands the network.

Northern RNA Inc

 

 

Join RNA Leaders next September

DOWNLOAD BROCHURE